Table 1 Baseline characteristics of study participants
Variables | Ginger group (n = 22) | Placebo group (n = 22) | P-value |
|---|---|---|---|
Age (years) | 60.05 ± 11.12 | 59.64 ± 10.69 | 0.902* |
Sex | 0.763†| ||
 Men (%) | 11 (50%) | 12 (54.5%) |  |
 Women (%) | 11 (50%) | 10 (45.5%) |  |
 Height (29) | 161.46 ± 8.70 | 161.76 ± 9.62 | 0.916* |
 Weight (kg) | 69.67 ± 10.76 | 74.55 ± 14.31 | 0.209* |
 BMI (kg.m−2) | 26.48 ± 3.71 | 28.41 ± 4.35 | 0.123* |
Dialysis Frequency | 0.709†| ||
 Two sessions per week | 4 (18.2%) | 5 (22.7%) |  |
 Three sessions per week | 18 (81.8%) | 17 (77.3%) |  |
Medication history | |||
 Insulin therapy | 5 (22.7%) | 4 (18.2%) | 0.709†|